Sudarshan Pharma Industries Limited - Company Profile

It is a professional services public limited company based in Mumbai, Maharashtra, India, established in 2008.

2008 Mumbai, Maharashtra, India Active

Last Updated: December 21, 2025

About Sudarshan Pharma Industries Limited

Sudarshan Pharma Industries Limited, a active public limited company, was established on 23 July 2008 in Mumbai, Maharashtra, India. Engaging in scientific within the professional, scientific and technical sector, it holds CIN: L51496MH2008PLC184997. Registered under ROC Roc Mumbai. it is listed. It has an authorized capital of ₹35.00 Cr and a paid-up capital of ₹24.07 Cr.

Formerly known as Sudarshan Pharma Industries Private Limited, Sudarshan Speciality Chemsolve Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹468.31 Cr and a net worth of ₹111.61 Cr. Employing 9 professional, Its leadership includes Jaya Ankur Singhania (Director), Vijay Ojha (Additional Director), Rushabh Prashant Patil (Director). Past directors included Rajesh Chandrakumar Hedaoo, Ujwala Vilas Salvi, Prakash Manmohan Vora. It holds ₹254.91 Cr open charges and ₹24.85 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 301,3Rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West), Mumbai, Maharashtra, 400092.

Company Details

CIN/LLPIN
L51496MH2008PLC184997
Registration Number
184997
Incorporation Date
23 July 2008
Authorized Capital
₹35.00 Cr
Paid-Up Capital
₹24.07 Cr
ROC Code
Roc Mumbai
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 35.00 Cr as on 21-12-2025
Paid Up Capital ₹ 24.07 Cr as on 21-12-2025
Company Age 17 Year, 6 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 254.91 Cr as on 21-12-2025
Satisfied Charges ₹ 24.85 Cr as on 21-12-2025
Revenue Growth **** 1.27% (FY 2024)
Profit Growth **** 61.30% (FY 2024)
Ebitda **** 53.17% (FY 2024)
Net Worth 10.53% (FY 2024)
Total Assets **** 22.53% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Sudarshan Pharma Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sudarshan Pharma Industries Limited?

Current Directors

Name	Designation	Appointment Date	Status
Jaya Ankur Singhania	Director	27 Dec 2022	Current
Vijay Ojha	Additional Director	18 Oct 2025	Current
Rushabh Prashant Patil	Director	21 Jul 2023	Current
Hemal Vasantrai Mehta	Managing Director	16 Jan 2015	Current
Sachin Vasantrai Mehta	Managing Director	23 Jul 2008	Current
Nirav Kishor Shah	Company Secretary	01 Jun 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	26 Sep 2022	Past
Pramod Abcsdd	Additional Director	31 Dec 2020	Past
Pramod Abcsdd	Additional Director	15 Jul 2021	Past
Pramod Abcsdd	Director	02 Feb 2019	Past
Pramod Abcsdd	Additional Director	12 Aug 2019	Past
Pramod Abcsdd	Additional Director	26 Sep 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sudarshan Pharma Industries.

Sudarshan Pharma Industries Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 1.27% increase. The company also saw a substantial improvement in profitability, with a 61.3% increase in profit. The company's net worth Soared by an impressive increase of 10.53%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

1.27%

*******

Revenue from Operations

*******

0.92%

*******

Total Assets

*******

22.53%

*******

Profit or Loss

*******

61.30%

*******

Net Worth

*******

10.53%

*******

EBITDA

*******

53.17%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sudarshan Pharma Industries?

In 2024, Sudarshan Pharma Industries had a promoter holding of 54.11% and a public holding of 45.89%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,549,122,183.00

Satisfied Charges

₹248,500,000.00

Charges Breakdown by Lending Institutions

Others : 176.96 Cr
Axis Bank Limited : 44.87 Cr
Indian Bank : 30.00 Cr
Tata Capital Financial Services Limited : 1.90 Cr
Hdfc Bank Limited : 1.18 Cr

Latest Charge Details

Date	Lender	Amount	Status
05 May 2025	Indian Bank	₹30.00 Cr	Open
26 Dec 2024	Others	₹48.00 Cr	Open
21 Nov 2024	Others	₹3.03 Cr	Open
29 Jul 2024	Hdfc Bank Limited	₹8.05 M	Open
13 May 2024	Others	₹5.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Sudarshan Pharma Industries?

Sudarshan Pharma Industries has a workforce of 9 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sudarshan Pharma Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudarshan Pharma Industries's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sudarshan Pharma Industries

Recent Activity within the Organization

Director Appointment

The activity Vijay Ojha was appointed as a Additional Director was appointed as a Additional Director on 18 Oct 2025 & has been associated with this company since 3 months 25 days . was completed.
18 Oct 2025
Charges

A charge with Axis Bank Limited of Rs. 43.53 Cr registered on 24 Feb 2021 with Charge ID 100440071 was modified on 31 Jul 2025. was recorded as a recent event.
31 Jul 2025
Charges

A charge with Others of Rs. 5.00 Cr registered on 13 May 2024 with Charge ID 100939428 was modified on 14 Jul 2025. was recorded as a recent event.
14 Jul 2025
Director Appointment

Progress on Manoj Lalchand Lodha was appointed as a Cfo was appointed as a Cfo on 24 May 2025 & has been associated with this company since 8 months 19 days . was documented.
24 May 2025
Charges

A charge with Indian Bank amounted to Rs. 30.00 Cr with Charge ID 101102756 was registered on 05 May 2025. was recorded as a recent event.
05 May 2025
Charges

Progress on A charge with Others of Rs. 40.98 Cr registered on 08 Sep 2023 with Charge ID 100784718 was modified on 21 Jan 2025. was documented.
21 Jan 2025

Explore recent activity and updates - View Recent Activity